We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
203.21%
This Fund
S&P 500
This Quarter
Est. Return
-0.86%
1 Year Est. Return
+203.21%
3 Year Est. Return
+364.25%
5 Year Est. Return
+595.91%
10 Year Est. Return
+10,683%
AUM
$1.14B
AUM Growth
-$165M
(-13%)
Cap. Flow
-$89.3M
Cap. Flow
% of AUM
-7.83%
Top 10 Holdings %
Top 10 Hldgs %
42.55%
Holding
55
New
5
Increased
22
Reduced
16
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FNA
Paragon 28, Inc.
FNA
|
+$37M |
| 2 |
LivaNova
LIVN
|
+$34.6M |
| 3 |
Evolent Health
EVH
|
+$29.5M |
| 4 |
Vera Therapeutics
VERA
|
+$22.6M |
| 5 |
Health Catalyst
HCAT
|
+$20.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$52.6M |
| 2 |
Transmedics
TMDX
|
+$49.3M |
| 3 |
iRhythm Holdings
IRTC
|
+$48.8M |
| 4 |
Natera
NTRA
|
+$29.2M |
| 5 |
MODN
MODEL N, INC.
MODN
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 97.29% |
| 2 | Industrials | 2.71% |
| 3 | Communication Services | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNA
1
DELISTED
Paragon 28, Inc.
FNA
| $55.9M | 4.9% |
8,174,832
+4,371,864
| +115% | +$37M |
|
2
Alphatec Holdings
ATEC
$1.66B
| $55.7M | 4.88% |
5,327,978
-90,653
| -2% | -$1.06M |
|
|
CRNX
3
DELISTED
Crinetics Pharmaceuticals
CRNX
| $53.8M | 4.71% |
1,200,508
-489,669
| -29% | -$22.6M |
|
4
NeoGenomics
NEO
$2.45B
| $52.5M | 4.6% |
3,782,561
+480,396
| +15% | +$6.81M |
|
5
Xenon Pharmaceuticals
XENE
$5.46B
| $50.9M | 4.46% |
1,306,260
-13,912
| -1% | -$556K |
|
|
6
Transmedics
TMDX
$3.09B
| $45.3M | 3.97% |
300,600
-411,082
| -58% | -$49.3M |
|
7
AtriCure
ATRC
$2.86B
| $44.7M | 3.92% |
1,964,703
+581,843
| +42% | +$13.4M |
|
8
Insulet
PODD
$9.67B
| $43.5M | 3.81% |
215,637
+64,373
| +43% | +$11.6M |
|
|
CNTA
9
DELISTED
Centessa Pharmaceuticals
CNTA
| $43.2M | 3.78% |
4,780,560
+1,778,515
| +59% | +$16.9M |
|
|
10
Natera
NTRA
$50.2B
| $40M | 3.5% |
369,068
-287,640
| -44% | -$29.2M |
|
11
Ultragenyx Pharmaceutical
RARE
$1.28B
| $39.6M | 3.47% |
963,146
+172,700
| +22% | +$7.37M |
|
|
12
LivaNova
LIVN
$4.39B
| $38.9M | 3.41% |
710,390
+607,598
| +591% | +$34.6M |
|
13
Insmed
INSM
$25.9B
| $36.9M | 3.24% |
551,303
+268,537
| +95% | +$10.4M |
|
14
Pliant Therapeutics
PLRX
$69.4M
| $36.6M | 3.21% |
3,401,213
-133,780
| -4% | -$1.72M |
|
|
15
Vera Therapeutics
VERA
$2.41B
| $36.4M | 3.19% |
1,005,723
+569,590
| +131% | +$22.6M |
|
16
SI-BONE Inc
SIBN
$845M
| $32M | 2.8% |
2,473,289
+124
| +0% | +$1.77K |
|
|
RCM
17
DELISTED
R1 RCM Inc. Common Stock
RCM
| $31M | 2.71% |
2,464,809
-87,516
| -3% | -$1.09M |
|
|
PHLT
18
DELISTED
Performant Healthcare Inc
PHLT
| $30.5M | 2.67% |
10,514,200
-927
| -0% | -$2.66K |
|
19
Oscar Health
OSCR
$10.1B
| $29.5M | 2.59% |
1,865,922
-236,632
| -11% | -$4.35M |
|
20
Tandem Diabetes Care
TNDM
$1.14B
| $28.5M | 2.5% |
708,482
+233,405
| +49% | +$9.74M |
|
|
BCYC
21
Bicycle Therapeutics
BCYC
$256M
| $28M | 2.46% |
1,384,768
+191,717
| +16% | +$4.33M |
|
|
22
Evolent Health
EVH
$431M
| $27.6M | 2.42% |
1,445,305
+1,157,124
| +402% | +$29.5M |
|
|
23
Health Catalyst
HCAT
$129M
| $25.3M | 2.22% |
3,956,089
+3,221,408
| +438% | +$20.7M |
|
24
Axogen
AXGN
$2.43B
| $24.2M | 2.12% |
3,344,033
+2,578,147
| +337% | +$17.6M |
|
25
Structure Therapeutics
GPCR
$2.74B
| $23.2M | 2.03% |
590,647
+441,534
| +296% | +$18.1M |
|
Similar funds
AAM
NPA
SOS
BCM
BFO
AAG
MCIL
TIM
First Light Asset Management's Q2 2024 Portfolio in Review
As of Q2 2024, First Light Asset Management held 55 positions worth $1.14B, down 13% from $1.31B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
First Light Asset Management withdrew a net $89.3M in Q2 2024, closing 11 positions and reducing 16 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $52.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier, followed by Industrials and Communication Services.
Against the trend, First Light Asset Management opened a new position in Savara worth $8.07M.
- First Light Asset Management's largest Q2 2024 buy was Savara: 2,002,219 shares worth $8.07M.
- First Light Asset Management added most to Paragon 28, Inc. in Q2 2024, an estimated $37M increase.
- First Light Asset Management's biggest Q2 2024 reduction was Transmedics, cutting an estimated $49.3M.
- First Light Asset Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $52.6M.
- First Light Asset Management's ten largest holdings make up 43% of its $1.14B portfolio in Q2 2024.
- First Light Asset Management opened 5 new positions and closed 11 in Q2 2024.
- First Light Asset Management's portfolio value fell 13% quarter-over-quarter to $1.14B.
Based on First Light Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.